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The genesis of hepatocellular carcinoma is promoted by changes in the regulatory MDM2-P14ARF system. The incidence of such
changes has to date not been analysed in non-tumourous livers showing regenerative proliferation. In the present study, 24
cirrhotic livers of alcohol-, autoimmue disorder- or HCV-caused genesis were screened for MDM2-P14ARF alterations at the level
of protein, DNA and mRNA. Using confocal laser scanning microscopy, the absence of MDM2 and P14ARF expression was
detected in all samples except three HCV-infected livers (four livers) which contained hepatocytes overexpressing MDM2
(P14ARF) protein. In two of the samples lacking P14ARF expression, laser microdissection and PCR demonstrated deletion of the
P14ARF gene. The P14ARF gene ampliﬁed from other specimens did not carry mutations. MDM2 splicing variants were present in
tissues from alcohol- and autoimmune disorder-induced cirrhoses. Sequencing of full-size mRNA revealed a MDM2 mis-sense
mutation in an alcohol-induced cirrhosis. One sample contained regenerative nodules with genetic instability occurring at MDM2
locus D12S83 according to the data of automatic PCR fragment analysis. In summary, this study gives ﬁrst evidence for different
types of MDM2 and P14ARF alterations in cirrhotic livers. We suggest that the changes impair the regulatory MDM2-P14ARF
system, thus possibly favouring regenerative proliferation and transformation.
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Hepatocellular carcinoma (HCC) is the most common primary
malignancy of the liver and the most common cancer in some
geographic areas (Simonetti et al, 1991). Epidemiologic studies
have demonstrated a correlation between high prevalence of viral
infection of the liver and the incidence of HCC. In western coun-
tries, hepatitis C virus (HCV) infection is detected in greater than
10% of patients with HCC and in up to 80% in Italy and Spain
(Okuda, 1997). Additionally, in Japan an increase in HCC inci-
dence has been attributed to an increase in HCV-associated HCC
while the incidence of HBV-induced HCC has not changed much
(Okuda, 1997).
Viral and toxin-induced mechanisms in the cirrhotic liver may
activate oncogenes and inactivate tumour suppressor genes. In this
context, the human oncogene MDM2 (Fakharzadeh et al, 1991) is a
candidate for promoting pathogenic changes in cirrhotic liver
tissue. It encodes a phosphoprotein which inhibits DNA repair
and apoptosis by forming a complex with tumour suppressor
p53 (Momand et al, 1992). Additionally, MDM2 interacts with cell
regulators such as the TATA-binding protein TBP and basal tran-
scription factor TAFII250 (Leveillard and Wasylyk, 1997), thus
emphasising the importance of MDM2 protein in the regulation
of cell division. Nucleocytoplasmic MDM2 accumulation represents
an important tumorigenic mechanism that immortalises ﬁbroblasts
(Finlay, 1993). In solid tumours, MDM2 overexpression is caused
by MDM2 gene ampliﬁcation (Ladanyi et al, 1993). Other genetic
MDM2 abnormalities are mutations in tumours that might prolong
the half-life of MDM2 (Schlott et al, 1997; 1999). Finally, MDM2
splicing variants with transforming potential were detected in
malignant neoplasms (Haines et al, 1994, Sigalas et al, 1996).
Recently, the tumour suppressor P14ARF was shown to inﬂuence
MDM2 function by binding and transporting MDM2 into the
nucleolus for inactivation (Tao and Levine, 1999; Weber et al,
1999). Homozygous deletions of the P14ARF gene promote accu-
mulation of MDM2 and ubiquitin ligase activity of MDM2 for
tumour suppressor p53 (Honda and Yasuda, 1999). The deletions
were detected in neoplasms such as lung carcinomas and malignant
peripheral nerve sheath tumours and were considered to be
involved in the process of tumorigenesis (Kourea et al, 1999;
Sanchez-Cespedes et al, 1999).
HCC usually develops in a liver with advanced chronic liver
disease and rarely develops in a normal liver. Since alterations of
the MDM2/P14ARF system have been observed in many human
tumours – including hepatocellular carcinoma – they may also
be present in cirrhotic liver thus representing early events in the
pathogenesis of the liver. The present study investigates this possi-
bility in detail.
MATERIALS AND METHODS
Liver samples
Peripheral blood and fresh/parafﬁn-embedded biopsates from 24
cases with cirrhotic liver were collected. The protocol was approved
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studied patients required liver transplantation because of underly-
ing liver cirrhosis. Fresh biopsates from a case with
hepatocellular carcinoma and from normal liver tissue served as
control in the immunoﬂuorescence staining. Diagnosis of cirrhosis
and HCC was based on histological ﬁndings. The aetiology of liver
cirrhosis was recognised as HCV-induced (n=10; 5 male, 5 female;
HBs antigen and HBV-DNA negative), alcohol-induced (n=9; 7
male, 2 female; HCV and HBV negative) and autoimmune liver
disease (n=5; 1 male, 4 female; primary biliary cirrhosis n=3,
primary sclerosing cholangitis n=1, autoimmune hepatitis n=1;
HCV and HBV negative). Neither dysplastic nodules nor hepato-
cellular carcinoma cells were observed in the cirrhotic tissue
samples analysed.
Immunoﬂuorescence analysis of MDM2 and P14ARF
protein expression
Single ﬂuorescence labelling was performed with cryosections.
Sections were rinsed in cold aceton (100%, 7208C) for 5 min
and washed three times in PBS (pH 7.2). The coverslips were
placed onto paraﬁlm into wet chamber and blocked by incubation
with human serum (DAKO, Denmark) for 30 min. Primary anti-
bodies MDM2 (NCL-MDM2, mouse monoclonal, Novocastra,
UK), P14ARF (FL-132, rabbit polyclonal, Santa Cruz Biotechnol-
ogy, USA) were diluted 1:20 in PBS and applied onto the
coverslips. After overnight incubation, the sections were washed
three times in PBS on a lab shaker. Afterwards secondary antibo-
dies were diluted in PBS 1:10 and added to the cryosections.
MDM2 antibody was detected using anti-mouse-labelled rabbit
antibody with ﬂuorescent dye FITC, P14ARF antibody was detected
with anti-rabbit-labelled swine antibody with ﬂuorescence dye
FITC (F205, DAKO, Denmark). Sections were incubated for 2 h
and washed three times in PBS. For mounting of the cover slips,
DAKO-R ﬂuorescent mounting medium was used. Microscopy
was performed with a Zeiss LSM 510 UV confocal microscope
(Carl Zeiss, Jena, Germany). Images were taken simultaneously in
transmitted light with differential interference contrast (DIC) and
in the confocal ﬂuorescence mode of the instrument. Sections from
hepatocellular carcinoma/normal liver tissue served as positive/
negative control.
DNA analysis
DNA extraction from white blood cells The DNA isolation kit
for mammalian blood (Roche, Germany) was used to isolate white
blood cells from peripheral blood and to extract the DNA. The
protocol was performed according to the manufacturer’s instruc-
tions.
Laser microdissection and DNA extraction For single-cell
DNA PCR, PEN membrane (PALM, Germany) was attached
to glass slides by dipping the slide into 70% ethanol and prick-
ing up a pre-cut piece of membrane. The membrane was ﬁxed
to the slide by tape. The slides were incubated with poly-L-
lysine (Sigma, Munich, Germany) and dried for 1 h at 378C.
5 mm sections were cut from formalin-ﬁxed, parafﬁn-embedded
sections or cryosections and transfered to the membranes.
Parafﬁn-embedded sections were incubated in xylene for
2615 min and rehydrated in ethanol (99%) for 2610 min,
in ethanol (96%) for 2610 min and in ethanol (70%) for
2610 min. All sections were counterstained with methylene
blue. Regenerative nodules were isolated by laser microdissec-
tion (laser microdissection system, PALM, Bernried, Germany)
according to the method of Schuetze and Lahr (1999). Cells
were transferred into 10 ml of a solution consisting of master
mix 1 and master mix 2 of the Expand
TM High Fidelity
PCR system (Roche, Mannheim, Germany) but lacking PCR
enzyme mix. This solution included 4 mg ml
71 proteinase K
(DAKO, Denmark) and 0.5% Tween 20 (Merck, Darmstadt,
Germany). Cell lysis was performed by incubation at 548C
overnight. On the following day proteinase K was inactivated
by heating the solution for 10 min at 948C. To increase the
quantity of whole genomic DNA, 40 ml of the Expand
TM High
Fidelity PCR solution were added, consisting of master mix 1,
master mix 2, 5U Taq Expand High Fidelity polymerase
(Roche, Mannheim, Germany), 25 mM MgCl2 and 5 ml 25 pmol
ml
71 random primer 5'-CCGACTCGAGNNNNNNATGTGG-3'.
In each run, test tubes were heated to 948C for 2 min,
followed by 10 PCR cycles (948C for 15 s, 408C for 30 s,
688C for 4 min) and 20 PCR cycles (948C for 15 s, 408C for
30 s, 688C for 4 min; cycle elongation for 5 s each cycle) and
a ﬁnal extension at 728C for 7 min. The resulting ampliﬁcation
products were used for conventional P14ARF PCR and micro-
satellite PCR.
Analysis of P14ARF gene deletion and gene mutation P14ARF
and MDM2 gene were co-ampliﬁed by multiplex PCR. P14ARF
primers yielding a 174 bp product were described by Newcomb
et al (1999). MDM2 DNA primers were 5'-CTCAACACAAGCT-
GAAGAGG-3' (sense primer) and 5'-ATTGGTTGTCTACATA
CTGG-3' (antisense primer) yielding a 399 bp product. In case
of negative P14ARF PCR, data were reafﬁrmed by seminested
PCR: 3 ml of the ﬁrst-run PCR mixture were transfered to a reac-
tion cup and ampliﬁed using ﬁrst-run P14ARF sense primer
(Newcomb et al, 1999) and primer 5'-TCACCAAGAACCTGCG-
CACC-3' (novel P14ARF antisense primer). These primers yield a
122 bp P14ARF fragment. The ﬁrst-run PCR solution consisted
of 5 ml1 0 6 PCR buffer (Pharmacia, Freiburg, Germany), 30 pg
primer, 10 mM of each dNTP (Pharmacia, Freiburg, Germany),
1 ml aliquot of pre-ampliﬁed DNA and 1 unit of Taq DNA poly-
merase (Pharmacia, Freiburg, Germany). When perfoming
second-run PCR, 3 ml ﬁrst-run product were used instead of pre-
ampliﬁed DNA. The ﬁnal volume was 50 ml. Thermal cycling was
performed according to Newcomb et al (1999). Resulting
P14ARF fragments were isolated from the gel using QIA Quick
PCR Puriﬁcation Kit (QIAGEN, Hilden, Germany) and automati-
cally sequenced.
Automatic analysis of MDM2 microsatellite instability Micro-
satellite marker D12S80 and D12S83 ﬂanking the MDM2 gene were
ampliﬁed using 1 ml aliquot of preampliﬁed DNA in a ﬁnal volume
of 20 ml for 30 cycles. After an initial 958C denaturation step for
1 min (3 min), cycles were performed at 948C (1 min), 568C
(1 min), and 728C (1 min), followed by a ﬁnal extension step at
728C for 7 min. PCR products were separated on a 3% (w v
71)
agarose gel and stained with ethidium-bromide. The reaction
mixture contained 20 pmol of each primer, 1 ml dNTP (10 mM
each), 5 ml PCR buffer (106), and 1 U Taq polymerase (Pharma-
cia, Germany). The primer sequences were obtained from
Genethon (Paris). Sense primer was labelled with ﬂuorescent dye
HEX. For ﬂuorescence-based analysis of fragments, 5 ml of each
PCR mix were loaded onto the ABI 310 DNA Analyser (Perkin-
Elmer, Germany). Additionally, internal size standard GENES-
CAN
TM, TAMRA (Perkin-Elmer, Germany) was added to the
mixture. After the run, peak shifts were detected with GENESCAN
software. If band shifts indicated instability, at least one repetition
of PCR was performed on the same DNA sample. Criterium for
loss of heterozygosity was a 50% lower ratio in signal intensity
in one of the alleles when comparing tumour with matched normal
sample.
RNA analysis
RNA preparation Total RNA was extracted according to Scharf
et al (2000) and stored at 7708C.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(8), 1290–1296MDM2 RT–PCR for detection of splicing variants A
GeneAmp RNA-PCR Kit was used according to the manufacturer’s
instructions (Perkin Elmer, Weiterstadt, Germany) using 1 ml RNA
solution and random hexamers. For ampliﬁcation of MDM2
sequences, PCR primers were used as previously described yielding
a 1536 bp product of full-size MDM2 mRNA (Sigalas et al, 1996).
Resulting PCR products were separated on 3% agarose gels and
stained with ethidium bromide.
Sequencing of RT–PCR fragments Full-size PCR fragments
and fragments with deleted exons were puriﬁed using QIA Quick
PCR Puriﬁcation Kit (QIAGEN, Hilden, Germany). Fragments
were labelled with the PRISM-Ready Reaction Dye Deoxy-TM
Terminator Cycle Sequencing Kit (Applied Biosystems, Weiterstadt,
Germany) and analysed in an ABI 310 analyzer.
RESULTS
An overview of the genetic and immunohistochemical data
described below is presented in Table 1.
MDM2 and P14ARF protein expression
Immunoﬂuorescence analysis was performed on the confocal laser
scanning microscope to investigate expression of the MDM2-
P14ARF system in 24 cirrhotic liver tissue samples. MDM2 and
P14ARF was absent in most of the samples. In regenerative nodules
of three HCV-infected livers, however, interspersed hepatocytes
were detected revealing spot-like overepression and nuclear accu-
mulation of MDM2 (Figure 1, A1, A2). Especially the nucleoli
were densely ﬁlled with MDM2 protein. Notably, these samples
did not express the regulatory P14ARF protein. In contrast, two
other HCV-infected livers, one alcohol-induced cirrhosis and one
cirrhosis induced by autoimmune disease contained areas showing
overexpression of P14ARF (Figure 1, B1, B2). The distribution of
hepatocytes expressing MDM2 or P14ARF was patchy. We could
not detect any geographical correlates with a particular zone. Other
cell types such as lymphocytes, biliary epithelium, endothelial cells,
or kupffer cells did not express the MDM2-P14ARF system (data
not shown).
MDM2 mRNA splicing and mutation
Total RNA was extracted from liver samples and analysed by RT–
PCR for alternative MDM2 mRNA splicing. Two HCV-infected
samples showed 680 bp fragments. Sequencing of these PCR
products indicated formation of artefacts. As a result, the HCV-
infected samples did not contain MDM2 mRNA splicing variants
(data not shown).
In contrast, a complex MDM2 splicing pattern was found in 7
out of 9 alcohol- and in all autoimmune disorder-induced
cirrhoses (Figure 2). Notably, some specimens of the latter group
did not contain full-size MDM2 mRNA. Sequencing of the frag-
ments identiﬁed two MDM2 transcripts with deleted exons that
were interspersed among ampliﬁcation artefacts (Figure 3).
MDM2 mRNA transcript A demonstrating a length of about 302
base pairs on the gel lacked bases between nucleotide position
512 (exon 5) and position 1817 (exon 12). Transcript B with a
length of 387 bp lacked bases between nucleotide 491 (exon 5)
and 1740 (exon 12). Transcript A was present in all positive tissues
whereas transcript type B was only found in ﬁve alcohol-induced
cirrhoses. The nucleotide sequences of both MDM2 transcripts
and the derived sequences of amino acids are presented in Figure
4. The amino acid sequence showed that translation of the
MDM2 splicing variants results in proteins with premature stop
codons. Additionally, the splicing caused alteration of the amino
acid sequence of the last nine (transcript A) and six (transcript
B) amino acid residues ﬂanking the stop codon.
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Table 1 Genetic alteration of the MDM2-P14ARF system in non-tumourous, HBV negative cirrhotic livers. Overview of the data of genetic analysis
and immunoﬂuorescence microscopy
Sample number Nuclear MDM2 MDM2 MDM2 Micro satellite Nuclear P14ARF P14ARF
and genesis accumulation Full-size mRNA mRNA splicing instability D12S83 accumulation gene deletion
HCV-induced
1 7 + 77 7 7
2 7 + 77 + 7
3+ + 77 7 +
4 7 + 77 7 7
5+ + 77 7 7
6 7 + 77 7 7
7+ + 77 7 +
8 7 + 77 7 7
9 7 + 77 + 7
10 7 + 77 7 7
Alcohol-induced
1 7+ + (A,B) 77 7
2 7 + (M) + (A,B) 77 7
3 7 + + (A,B) + + 7
4 7 + + (A) 77 7
5 7 + + (A) 77 7
6 7 + + (B) 77 7
7 7 + 77 7 7
8 7 + + (B) 77 7
9 7 + 77 7 7
Autoimmune disease-induced
1 77 + (A) 77 7
2 77 + (A) 7 + 7
3 7+ + (A) 77 7
4 7 + + (A) 77 7
5 77 + (A) 77 7
Abbreviations: 7=no; +=yes; +=weak signals; (M)=MDM2 gene mutation; (A,B)=MDM2 mRNA transcript type A,B.
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British Journal of Cancer (2002) 86(8), 1290–1296 ã 2002 Cancer Research UKA novel MDM2 gene mutation was detected in an alcohol-
induced cirrhotic liver. The mutation is located between zinc ﬁnger
1 and the C-terminal RING ﬁnger domain at position 1605 of the
published sequence (Fakharzadeh et al, 1991). It replaces amino
acid residue Leu (CTT) by Val (GTT). Interestingly, the corre-
sponding electropherogram shows a sharp blue peak as well as a
smaller black peak which represents the nucleotide of the wild type
MDM2 sequence (Figure 5, upper sequence). It is possible that the
PCR reaction contains a mixture of mutant and non-mutant
MDM2 fragments. This analysis was repeated three times using
different cDNA aliquots of the same liver sample to conﬁrm the
data.
P14ARF gene deletion and gene mutation
Since most of the cirrhotic liver tissues lacked P14ARF expression,
laser microdissection was performed to isolate regenerative nodules
and characterise the genetic status of tumour suppressor P14ARF.
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500 bp —
400 bp —
300 bp —
300 bp —
A       B      C       D      E       F      G       H       I       J       K
Figure 2 Detection of MDM2 mRNA splicing variants in alcohol-induced
cirrhoses (four samples are shown exemplarily in lane C-F; B contains po-
sitive control) and in ﬁve autoimmune disease-induced liver cirrhoses (lanes
G–K). The samples were HCV negative. Lane A shows molecular weight
standard. PCR fragments were separated on 3% agarose gel. The alcohol-
and autoimmune disorder-induced cirrhoses express a spectrum of aber-
rant transcripts. Note that all tissues express full-length MDM2 RNA of
1536 bp except samples H, I, K which only contains splicing variants of
MDM2 mRNA. Lanes A, B and E contain faint bands indicating low amounts
of normal MDM2 mRNA.
Figure 1 Immunoﬂuorescence analysis of MDM2 and P14ARF expres-
sion in two cases of liver cirrhosis using confocal laser scanning microscopy.
Different areas from regenerative nodules are presented containing hepa-
tocytes overexpressing the proteins (bar: 10 mm). The upper row contains
the images in confocal ﬂuorescence. In the lower row, the ﬂuorescence was
combined with the transmitted light image in differential interference to re-
veal the structural aspect of the section. Pictures A1 and A2 refer to a cir-
rhotic liver sample showing MDM2 accumulation. Note the variations in
nuclear MDM2 staining throughout the section: Some nuclei reveal absence
of MDM2, others show spot-like nuclear expression, while others reveal a
string-like distribution in the nucleus. The nucleoli are strongly stained. Pic-
tures B1 and B2 contain another cirrhotic liver sample. The ﬁgures show
spot-like clusters of P14ARF in the nuclei of hepatocytes.
Exon 5 Exon 12
Exon 5 Exon 12
A
B
170
Figure 3 Sequence analysis of MDM2 mRNA splicing variants performed
in the automatic DNA analyser. The electropherograms indicate two RNA
transcripts differing from subtype a-e published by Sigalas et al, 1996.
mRNA (A) and (B) reveal sequence deletions between exon 5 and exon
12. Note the overlapping black and blue peak in sequence B (,,N‘‘) which
may indicate heterozygous alteration (G«C). However, reverse sequen-
cing of this stretch resulted in normal MDM2 sequence (data not shown).
Transcript Variant A
Exon 12 (non-coding sequence) Exon 5
--- AAA CGA TTA TAT ATT  TCT   AAC TAT ATA ACC CTA GGA ATT TAG ---
K      R    L     Y       I     S     N      Y      I      T      L     G      I   Stop
Transcript Variant B
Exon 12 (non-coding sequence) Exon 5
--- CTT   GGC   CAG TAT GTA GAC   AAC CAA  TTC   AAA  TGA ---
L     G       Q      Y     V      D      N     Q     F     K   Stop
Figure 4 Overview on nucleotide sequence of aberrant MDM2 mRNA
splicing transcripts detected in cirrhotic livers and on the amino acid com-
position of the proteins coded by the transcripts. In transcript A (upper se-
quence), exons are deleted and the reading frame is destroyed by a non-
sense mutation (stop codon). The amino acid sequence I-S-N-Y-I-T-L-G-I-
is induced by a shift of the reading frame. The sequence does not occurr in
wild type MDM2 protein. For concerning transcript B, bases are deleted
and the reading frame is destroyed by a premature termination codon.
The abnormal amino acid sequence -V-D-N-Q-F-K is the result of frame
shift.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(8), 1290–1296Nodules were isolated from fresh and parafﬁn-embedded sections.
P14ARF/MDM2 multiplex PCR was performed and demonstrated
loss of both P14ARF alleles in nodules isolated from two HCV-
infected livers (Figure 6). Lack of P14ARF gene was reafﬁrmed
by seminested P14ARF PCR (data not shown). In all other samples
P14ARF fragments were ampliﬁed which were isolated from agar-
ose gel and automatically sequenced. Gene mutations were not
detected.
MDM2 microsatellite instability
Nodules were isolated from sections of cirrhotic liver and analysed
for chromosomal instability. Using PCR the microsatellite markers
D12S83 and D12S80 were ampliﬁed which ﬂank a stretch of about
8.2 cM, covering the entire MDM2 gene locus at q13-14. Normal
cells (white blood cells from peripheral blood, normal human cells
obtained from histological sections by microdissection) served as
reference. The fragments labelled with a ﬂuorescent dye were sized
using GENESCAN software of the ABI 310 Analyzer. Additionally,
the quantity of each fragment was measured and compared with
the fragments obtained from other regenerative nodules and from
normal cells. Gain of copy number or loss of heterozygosity was
not detected. However, band shifting was observed for locus
D12S83 in a regenerative nodule from a cirrhosis with alcohol-
induced genesis, indicating chromosomal instability (Figure 7).
DISCUSSION
The pathogenesis of hepatocellular carcinoma is a focal and step-
wise process involving formation of preneoplastic and neoplastic
lesions in cirrhotic tissue. One of the early events in liver carcino-
genesis is p53 overexpression, which has been detected in nodules
of non-tumourous liver cirrhosis and which is considered to indi-
cate a cellular stress response preceding manifestation of HCC
(Livni et al, 1995). P53 is bound by oncoprotein MDM2 which
may also contribute to hepatocarcinogenesis since MDM2 overex-
pression as a potential tumorigenic event was demonstrated in
preneoplastic rat hepatocytes as well as in human HCC (Endo et
al, 2000; Van Gijssel et al, 2000).
The present study proves that MDM2 accumulation is also a
feature of some regenerative nodules in human cirrhotic livers.
Since MDM2 was overexpressed exclusively in samples infected
with HCV, one may speculate that viral products interacting with
cellular regulators trigger MDM2 expression. The core protein of
HCV, for example, was recently shown to repress transcription of
regulator p21, thus promoting the proliferation of hepatocytes
(Ray et al, 1998). We speculate that MDM2 accumulation may
be a side effect of comparable protein interactions. Another expla-
nation for the MDM2 protein overexpression is the loss of control
by the P14ARF gene which was deleted in two out of three cases
revealing MDM2 accumulation. The overexpression was not
caused by MDM2 mutations formerly found in hepatocellular
carcinoma (Schlott et al, 1997, 1999) since none of the three
samples accumulating MDM2 demonstrated corresponding
changes. However, a novel MDM2 gene mutation was found in
a non-expressing, alcohol-induced cirrhosis. This result gives ﬁrst
evidence that benign proliferative hepatocytes in cirrhotic tissue
also contain MDM2 gene mutation. The alteration causes a
Leu?Val conversion in MDM2 protein and may inﬂuence
secondary structure and function of the regulatory zinc ﬁnger
region.
Most of the cirrhotic livers – including the samples overex-
pressing MDM2 protein – appeared to lack P14ARF protein
as could be concluded by the immunoﬂuorescence staining with
a single antibody. In some of the regenerative nodules, this effect
was caused by homozygous P14ARF gene deletions. Comparable
deletions were described in hepatocellular carcinoma for the
P16(INK4A) gene encoding P14ARF protein by alternative spli-
cing (Jin et al, 2000). In liver cirrhosis, the affected
hepatocytes may be more susceptible to tumorigenic stimuli lead-
ing to MDM2 overepression since MDM2 can no longer be
bound by P14ARF and transported into the nuclei for inactiva-
tion (Tao and Levine, 1999; Weber et al, 1999). Inactivating
P14ARF gene mutations recently found in a collective of osteo-
sarcomas and Ewing sarcomas (Tsuchiya et al, 2000) may be
behind the lack of P14ARF expression in the other regenerative
nodules. However, our data did not reveal P14ARF gene muta-
tions, though destabilising mutations may still be located in
other parts of the P14ARF gene.
To our knowledge, this is the ﬁrst report on aberrant splicing of
MDM2 mRNA in liver cirrhosis. The transcript composition
revealed that important motifs were deleted. For example, tran-
scripts A and B lacked the ID1 and ID2 sequence that code for
domains inhibiting cell cycle progression (Brown et al, 1998). It
is thus possible that these proteins function as accelerators of cell
division. Remarkably, in some of the samples only altered
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Figure 5 Automatic sequencing of MDM2 mRNA isolated from an alco-
hol-induced cirrhosis. The upper sequence represents mutant transcript A.
The sequence below contains wild type MDM2 gene. The PCR fragments
were sequenced using anti-sense primer.
A               B             C              D
MDM2
P14
Figure 6 P14ARF gene deletion analysis in different cirrhotic livers. Hepa-
tocytes were isolated from regenerative nodules revealing lack of P14ARF
protein expression or MDM2 overexpression. DNA was isolated from mi-
crodissected cells and used for multiplex PCR. P14ARF sequence was
coampliﬁed with MDM2 sequence. The upper band represents the
MDM2 fragment, the lower band shows the P14ARF fragment. In lanes
A–D, 10 ng of DNA were ampliﬁed in reaction tubes. Data show that
the regenerative nodules analysed in lanes B and C lack the P14ARF gene.
These results were reafﬁrmed by repeating the PCR with another DNA
aliquot obtained from the same nodule. Consequently, the cell cycle in
these is no longer controlled by protein P14ARF.
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British Journal of Cancer (2002) 86(8), 1290–1296 ã 2002 Cancer Research UKMDM2 molecules – not the normal 90 kDa MDM2 proteins –
must have been present since in three cases of autoimmune
disease-induced cirrhosis the aberrant MDM2 mRNA type A was
found but not the normal full-size MDM2 mRNA. This dispropor-
tion of MDM2 proteins, to our knowledge not yet described in the
literature, may inﬂuence cell regulation and respectively tumorigen-
esis. It is not clear why alcohol- or autoimmune disorder-induced
cirrhosis but none of the HCV-induced cases showed MDM2
mRNA splicing. This signiﬁcant result may indicate that HCV
infections suppress some unknown mechanisms of MDM2 mRNA
splicing. Moreover, this study provides a ﬁrst clue to MDM2 splice
variant analysis in cirrhosis of different origins. The HCV-induced
cases were negative and transcript B was only detected in alcohol-
induced cirrhosis. Analyses of a larger collective of patients are
necessary to determine whether the MDM2 mRNA splicing pattern
could be of diagnostic relevance.
Another phenomenon known to be associated with liver cirrho-
sis as well as hepatocellular carcinoma is microsatellite instability
and LOH in the DNA repair genes MLH1/MSH2 and in the
tumour suppressor gene Rb (Ashida et al, 1997; Macdonald et al,
1998). LOH in the tumour suppressor genes p53, Rb1, EXT1 and
APC has been associated with hepatocellular carcinomas (Piao et
al, 1997). In the present study, a microsatellite marker ﬂanking
the MDM2 gene revealed instability in regenerative nodules isolated
from a cirrhotic sample. It is possible that genetic instability at the
MDM2 gene locus represents another feature of hepatocytes losing
control over cell cycle regulation. This ﬁnding is sufﬁcient ground
for analysing liver cirrhoses with a panel of microsatellite markers
covering the entire MDM2 gene locus to more accurately character-
ise chromosomal imbalance at chromosome 12q13-14.
In summary, hepatocytes in regenerative liver nodules reveal
changes in the MDM2-P14ARF system that are often observed in
human tumours. We speculate that the alterations may inﬂuence
the function and stochiometry of both regulators, thus promoting
cell proliferation and genesis of liver changes. Further analyses on a
larger pool of cirrhoses may help deﬁne the diagnostic and prog-
nostic importance of MDM2-P14ARF changes.
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Figure 7 Analysis of microsatellite instability at the MDM2 gene locus. Microsatellite marker D12S83 was ampliﬁed using DNA isolated from normal cells
and two different regenerative nodules of a cirrhotic liver sample. The fragments were ampliﬁed using sense primers labelled with ﬂuorescence dye and sized
in the ABI310 DNA analyzer by GENESCAN software. MDM2 allele peaks and PCR fragments resulting from Taq polymerase ,,stuttering‘‘ are presented in
the electropherogram each. Upper part: electropherogram of normal human cells obtained from the patient material by microdissection. Both MDM2 alleles
are indicated by the grey peaks (95 bp and 102 bp). The red peaks refer to the internal size standard. Identical peak pattern was obtained with DNA ex-
tracted from white blood cells of the patient. Middle part: electropherogram of a regenerative nodule revealing (a) loss of the left allele peak (b) formation of
two peaks of about 97 and 101 bp (c) conservation of the 102 bp allele peak. This pattern indicates chromosomal instability. Lower part: Another regen-
erative nodule of the same patient: The analysis shows normal pattern.
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